ArticleFrontiers in veterinary science2026
Assessment of the hepatoprotective effect of a multi-component preparation containing phospholipids, selected amino acids, betaine, and milk thistle extract in dogs with asymptomatic elevation of liver parameters: a pilot study.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver diseases in dogs are often diagnosed at advanced stages due to the organ's high functional reserve. Early supportive therapy with hepatoprotective nutraceuticals may help slow disease progression in dogs with asymptomatic elevation of liver parameters. Aim: The aim of this pilot study was to evaluate the hepatoprotective effect of a multi-component preparation containing phospholipids, selected amino acids, betaine, and milk thistle extract in client-owned dogs with asymptomatic elevation of liver parameters. Materials and methods: Seventeen dogs were included in the open-label study. The animals received Hepatiale Forte Advanced (Vet Expert) for 8 weeks at the manufacturer's recommended dose. Liver enzyme activities (ALT, AST, ALP, GGT), total bilirubin, serum bile acids, hematological parameters, and abdominal ultrasonography were assessed at baseline and after 8 weeks. Results: Supplementation resulted in statistically significant reductions in ALT ( Conclusion: Eight-week supplementation with the multi-component hepatoprotective preparation was associated with significant improvement in liver biochemical parameters in dogs with asymptomatic elevation of liver parameters. The results support further research in a randomized, placebo-controlled trial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.